Manufacturing Viral Vectors for the Next Phase of CGT - Top-Institutions - MDSpire

Manufacturing Viral Vectors for the Next Phase of CGT

As the sector matures, scalable vector production and robust analytical control are becoming essential to clinical and commercial success

  • April 30, 2026

  • 8 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    National Institutes of Health (NIH) - National Center for Advancing Translational Sciences (NCATS)
    National Institutes of Health (NIH) - National Center for Advancing Translational Sciences (NCATS)

    Bethesda, MD

    Key Differentiators

    • Gene Therapy
    • Viral Vector Manufacturing
    • Translational Science

  • #2

    University of Pennsylvania - Gene Therapy Program
    University of Pennsylvania - Gene Therapy Program

    Philadelphia, PA

    Key Differentiators

    • Gene Therapy
    • Viral Vector Production
    • Clinical Translation

  • #3

    Stanford University - Institute for Stem Cell Biology and Regenerative Medicine
    Stanford University - Institute for Stem Cell Biology and Regenerative Medicine

    Stanford, CA

    Key Differentiators

    • Cell Therapy
    • Viral Vector Manufacturing
    • Regenerative Medicine

  • #4

    Cincinnati Children's Hospital Medical Center - Gene Therapy Program
    Cincinnati Children's Hospital Medical Center - Gene Therapy Program

    Cincinnati, OH

    Key Differentiators

    • Gene Therapy
    • Viral Vector Manufacturing
    • Pediatric Rare Diseases

  • #5

    Massachusetts General Hospital - Center for Cell Engineering
    Massachusetts General Hospital - Center for Cell Engineering

    Boston, MA

    Key Differentiators

    • Cell and Gene Therapy
    • Viral Vector Manufacturing
    • Clinical Translation

Original Source(s)

Manufacturing Viral Vectors for the Next Phase of CGT

  • April 30, 2026

Related Content

Comprehensive analysis of fatty acid desaturase 3 in clear cell renal cell carcinoma: insights into tumor progression, immune microenvironment, and clinical outcomes

Efficacy and Safety of Neoadjuvant Therapies for High-Risk and Locally Advanced Prostate Cancer in Older Adults: A Systematic Review and Network Meta-Analysis

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report